Xiang He Capital

The firm covers the full spectrum from seed-stage startups through growth and late-stage expansion rounds, operating as a generalist venture and growth equity investor within China. The strategy allows it to enter at a company's earliest institutional round and follow on in subsequent financings. The firm's stage flexibility is typical of China-based managers who build concentrated portfolios around long-term sector theses.

Xiang He Capital invests across enterprise software, artificial intelligence and machine learning, industrial technology, and healthcare services. The sector mix spans both software-driven and operational-technology businesses, reflecting the diversification pattern common among China-focused growth equity firms. The firm has not publicly disclosed specific sector exclusions.

The firm is categorized as an asset manager with a private equity and venture capital mandate, not a family office. Its funding structure and LP base have not been publicly disclosed, which leaves open the possibility of a concentrated or proprietary capital base. The firm's deliberately low public profile has not clarified whether it operates pooled third-party funds or a single-LP vehicle.

Xiang He Capital sources investments through Beijing-based networks within China's domestic technology and healthcare ecosystems. Like many relationship-driven China managers, its sourcing likely relies on founder referrals, on-the-ground sector specialists, and repeat-entrepreneur networks. The firm's absence from public platforms suggests its pipeline runs through private channels rather than marketed or intermediated deal flow.

The firm's investment activity is concentrated in Greater China, with no public record of cross-border direct investments. Its Beijing headquarters and China-focused sector strategy indicate a domestic-first mandate. External deal databases have not captured any disclosed ex-China transactions as of the latest available data.